MGX
Price
$1.46
Change
-$0.13 (-8.18%)
Updated
Jun 27 closing price
Capitalization
55.7M
45 days until earnings call
SABS
Price
$1.69
Change
-$0.09 (-5.06%)
Updated
Jun 27 closing price
Capitalization
16.07M
Interact to see
Advertisement

MGX vs SABS

Header iconMGX vs SABS Comparison
Open Charts MGX vs SABSBanner chart's image
Metagenomi
Price$1.46
Change-$0.13 (-8.18%)
Volume$3.62M
Capitalization55.7M
SAB Biotherapeutics
Price$1.69
Change-$0.09 (-5.06%)
Volume$18.81K
Capitalization16.07M
MGX vs SABS Comparison Chart in %
Loading...
MGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SABS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MGX vs. SABS commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGX is a Hold and SABS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (MGX: $1.46 vs. SABS: $1.69)
Brand notoriety: MGX and SABS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGX: 770% vs. SABS: 45%
Market capitalization -- MGX: $55.7M vs. SABS: $16.07M
MGX [@Biotechnology] is valued at $55.7M. SABS’s [@Biotechnology] market capitalization is $16.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGX’s FA Score shows that 1 FA rating(s) are green whileSABS’s FA Score has 0 green FA rating(s).

  • MGX’s FA Score: 1 green, 4 red.
  • SABS’s FA Score: 0 green, 5 red.
According to our system of comparison, both MGX and SABS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGX’s TA Score shows that 6 TA indicator(s) are bullish while SABS’s TA Score has 3 bullish TA indicator(s).

  • MGX’s TA Score: 6 bullish, 3 bearish.
  • SABS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, MGX is a better buy in the short-term than SABS.

Price Growth

MGX (@Biotechnology) experienced а +0.69% price change this week, while SABS (@Biotechnology) price change was -5.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

MGX is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGX($55.7M) has a higher market cap than SABS($16.1M). SABS YTD gains are higher at: -55.458 vs. MGX (-59.557). SABS has higher annual earnings (EBITDA): -30.38M vs. MGX (-82.2M). MGX has more cash in the bank: 226M vs. SABS (12.9M). SABS has less debt than MGX: SABS (6.78M) vs MGX (44.4M). MGX has higher revenues than SABS: MGX (45.3M) vs SABS (0).
MGXSABSMGX / SABS
Capitalization55.7M16.1M346%
EBITDA-82.2M-30.38M271%
Gain YTD-59.557-55.458107%
P/E RatioN/AN/A-
Revenue45.3M0-
Total Cash226M12.9M1,752%
Total Debt44.4M6.78M655%
TECHNICAL ANALYSIS
Technical Analysis
MGXSABS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 18 days ago
70%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
MGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SABS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OCLCF123.3229.83
+31.91%
Oracle Corp.
AFGYF0.210.01
+3.48%
AFC Energy Plc.
THDDY18.12N/A
N/A
TV Asahi Holdings Corp.
CNLPL52.04N/A
N/A
Connecticut Light & Power Co. (The)
PRVCF0.03N/A
-9.16%
PreveCeutical Medical Inc.

MGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGX has been loosely correlated with KOD. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MGX jumps, then KOD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGX
1D Price
Change %
MGX100%
-8.18%
KOD - MGX
42%
Loosely correlated
-2.38%
KYTX - MGX
36%
Loosely correlated
-5.48%
CDXS - MGX
34%
Loosely correlated
-5.16%
SABS - MGX
33%
Loosely correlated
-5.06%
CVM - MGX
33%
Poorly correlated
-1.64%
More

SABS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SABS has been loosely correlated with LPTX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SABS jumps, then LPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SABS
1D Price
Change %
SABS100%
-5.06%
LPTX - SABS
48%
Loosely correlated
-6.47%
MGX - SABS
33%
Loosely correlated
-8.18%
INKT - SABS
29%
Poorly correlated
-6.31%
SLS - SABS
28%
Poorly correlated
-3.94%
WHWK - SABS
26%
Poorly correlated
+1.58%
More